Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fujimoto

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Neuroscience Research|July 1, 1996
GTP-binding protein activation underlies LTP induction by mast cell degranulating peptideI Fujimoto, S Oiki, T Kondo, et al.
Neuroscience Research|April 1, 1992
K+ channel involvement in induction of synaptic enhancement by mast cell degranulating (MCD) peptideT Kondo, K Ikenaka, I Fujimoto, et al.
Acta Paediatrica Japonica : Overseas Edition|December 1, 1991
Giant hydroureteronephrosis associated with primary obstructed megaureterH Tsukahara, T Ando, Y Fujii, et al.
The New England Journal of Medicine|June 24, 1993
Risk factors for hepatocellular carcinoma among patients with chronic liver diseaseH Tsukuma, T Hiyama, S Tanaka, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1988
A comparative epidemiologic study on geographic distributions of cancers of the lung and the large intestine in JapanM Murata, K Takayama, S Fukuma, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1992
Diagnostic validity of fecal occult blood tests for detecting gastroenterological cancersR Murakami, T Otani, K Nakanishi, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1994
Case-control study for lung cancer and cigarette smoking in Osaka, Japan: comparison with the results from Western EuropeT Sobue, T Suzuki, I Fujimoto, et al.
International Journal of Cancer|February 15, 1990
A case-control study of hepatocellular carcinoma in Osaka, JapanH Tsukuma, T Hiyama, A Oshima, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1991
Lung cancer risk among exsmokersT Sobue, T Suzuki, I Fujimoto, et al.
Nihon Sanka Fujinka Gakkai Zasshi|May 1, 1991
[Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin]Y Shimizu, K Nakayama, Y Seimiya, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Neuroscience Research|July 1, 1996
GTP-binding protein activation underlies LTP induction by mast cell degranulating peptideI Fujimoto, S Oiki, T Kondo, et al.
Neuroscience Research|April 1, 1992
K+ channel involvement in induction of synaptic enhancement by mast cell degranulating (MCD) peptideT Kondo, K Ikenaka, I Fujimoto, et al.
Acta Paediatrica Japonica : Overseas Edition|December 1, 1991
Giant hydroureteronephrosis associated with primary obstructed megaureterH Tsukahara, T Ando, Y Fujii, et al.
The New England Journal of Medicine|June 24, 1993
Risk factors for hepatocellular carcinoma among patients with chronic liver diseaseH Tsukuma, T Hiyama, S Tanaka, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1988
A comparative epidemiologic study on geographic distributions of cancers of the lung and the large intestine in JapanM Murata, K Takayama, S Fukuma, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1992
Diagnostic validity of fecal occult blood tests for detecting gastroenterological cancersR Murakami, T Otani, K Nakanishi, et al.
Japanese Journal of Cancer Research : Gann|May 1, 1994
Case-control study for lung cancer and cigarette smoking in Osaka, Japan: comparison with the results from Western EuropeT Sobue, T Suzuki, I Fujimoto, et al.
International Journal of Cancer|February 15, 1990
A case-control study of hepatocellular carcinoma in Osaka, JapanH Tsukuma, T Hiyama, A Oshima, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1991
Lung cancer risk among exsmokersT Sobue, T Suzuki, I Fujimoto, et al.
Nihon Sanka Fujinka Gakkai Zasshi|May 1, 1991
[Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin]Y Shimizu, K Nakayama, Y Seimiya, et al.
Pageof 18